NUVAXOVID (COVID-19 Vaccine, Adjuvanted)

Nuvaxovid will have 30-90 days dating per manufacturer specifications.  The product is returnable for credit upon expiration.

COVID-19 Vaccine, adjuvanted injectable suspension, for intramuscular use 2025-2026 formula

For use in patients 65 years of age and older, or 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19